{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:18:37Z","timestamp":1790468317405,"version":"4.1.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"suppl_4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"DOI":"10.1093\/jac\/dky050","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T20:10:26Z","timestamp":1519157426000},"page":"iv2-iv5","source":"Crossref","is-referenced-by-count":73,"title":["T2 magnetic resonance for the diagnosis of bloodstream infections: charting a path forward"],"prefix":"10.1093","volume":"73","author":[{"given":"Cornelius J","family":"Clancy","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Hong","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,28]]},"reference":[{"key":"key\n\t\t\t\t20180328000318_dky050-B1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t20180328000318_dky050-B2","doi-asserted-by":"crossref","first-page":"119.","DOI":"10.1186\/s13054-017-1696-z","article-title":"Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremia","volume":"21","author":"Lee","year":"2017","journal-title":"Crit Care"},{"key":"key\n\t\t\t\t20180328000318_dky050-B3","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \u201cmissing 50%\u201d of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care","volume":"56","author":"Clancy","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328000318_dky050-B4","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.2016.14655","article-title":"Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, Candida colonization, and multiple organ failure: the EMPIRICUS randomized clinical trial","volume":"316","author":"Timsit","year":"2016","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328000318_dky050-B5","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cis023","article-title":"The end of an era in defining the optimal treatment of invasive candidiasis","volume":"54","author":"Clancy","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328000318_dky050-B6","doi-asserted-by":"crossref","first-page":"182ra54.","DOI":"10.1126\/scitranslmed.3005377","article-title":"T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood","volume":"5","author":"Neely","year":"2013","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20180328000318_dky050-B7","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/cid\/ciu959","article-title":"T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial","volume":"60","author":"Mylonakis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328000318_dky050-B8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2217\/fmb.15.111","article-title":"T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis","volume":"11","author":"Pfaller","year":"2016","journal-title":"Future Microbiol"},{"key":"key\n\t\t\t\t20180328000318_dky050-B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328000318_dky050-B10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/JCM.01602-10","article-title":"PCR diagnosis of invasive candidiasis: systematic review and meta-analysis","volume":"49","author":"Avni","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328000318_dky050-B11","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials","volume":"54","author":"Andes","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328000318_dky050-B12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study","volume":"43","author":"Garey","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328000318_dky050-B13","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328000318_dky050-B14","doi-asserted-by":"crossref","first-page":"iv6","DOI":"10.1093\/jac\/dky047","article-title":"T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study","volume":"73","author":"Mu\u00f1oz","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328000318_dky050-B15","doi-asserted-by":"crossref","first-page":"iv27","DOI":"10.1093\/jac\/dky046","article-title":"Impact of rapid, culture independent diagnosis of candidemia and invasive candidiasis in a community health system","volume":"73","author":"Patch","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328000318_dky050-B16","doi-asserted-by":"crossref","first-page":"iv13","DOI":"10.1093\/jac\/dky048","article-title":"T2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study","volume":"73","author":"Mu\u00f1oz","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328000318_dky050-B17","doi-asserted-by":"crossref","first-page":"iv20","DOI":"10.1093\/jac\/dky049","article-title":"T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood","volume":"73","author":"De Angelis","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328000318_dky050-B18","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1586\/14787210.2014.919853","article-title":"Undiagnosed invasive candidiasis: incorporating non-culture diagnostics into rational prophylactic and preemptive antifungal strategies","volume":"12","author":"Clancy","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key\n\t\t\t\t20180328000318_dky050-B19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3109\/23744235.2015.1028100","article-title":"Incidence and mortality of sepsis, severe sepsis, and septic shock in intensive care unit patients with candidemia","volume":"47","author":"Ng","year":"2015","journal-title":"Infect Dis (Lond)"},{"key":"key\n\t\t\t\t20180328000318_dky050-B20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/321811","article-title":"Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey","volume":"33","author":"Blumberg","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328000318_dky050-B21","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","article-title":"Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"340","author":"Walsh","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328000318_dky050-B22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":"Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever","volume":"346","author":"Walsh","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328000318_dky050-B23","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa040446","article-title":"Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia","volume":"351","author":"Walsh","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328000318_dky050-B24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7326\/0003-4819-135-6-200109180-00010","article-title":"Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial","volume":"135","author":"Boogaerts","year":"2001","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180328000318_dky050-B25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10096-007-0270-z","article-title":"Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting","volume":"26","author":"Ostrosky-Zeichner","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180328000318_dky050-B26","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1097\/CCM.0b013e31819daa14","article-title":"Usefulness of the \u2018Candida score\u2019 for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study","volume":"37","author":"Leon","year":"2009","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t20180328000318_dky050-B27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.diagmicrobio.2006.03.013","article-title":"The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients","volume":"55","author":"Magill","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180328000318_dky050-B28","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/cid\/ciu074","article-title":"MSG-01: a randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting","volume":"58","author":"Ostrosky-Zeichner","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328000318_dky050-B29","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/cid\/ciw610","article-title":"Problematic dichotomization of risk for intensive care unit (ICU)-acquired invasive candidiasis: results using a risk-predictive model to categorize 3 levels of risk from a multicenter prospective cohort of Australian ICU patients","volume":"63","author":"Playford","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328000318_dky050-B30","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation \u2013 a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328000318_dky050-B31","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328000318_dky050-B32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-118-7-199304010-00003","article-title":"Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial","volume":"118","author":"Winston","year":"1993","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180328000318_dky050-B33","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood.V96.6.2055","article-title":"Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial","volume":"96","author":"Marr","year":"2000","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180328000318_dky050-B34","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cix1095","article-title":"Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): a prospective, multicenter study of the T2Candida Panel","author":"Clancy","year":"2018","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/suppl_4\/iv2\/24455457\/dky050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T10:16:06Z","timestamp":1603880166000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/suppl_4\/iv2\/4951491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,1]]},"references-count":34,"journal-issue":{"issue":"suppl_4","published-online":{"date-parts":[[2018,3,28]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky050","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2018,3,1]]}}}